Summary: Neurovalens, maker of the FDA-cleared Modius Sleep device for chronic insomnia, will join the National Sleep Foundation (NSF) at CES 2025 to participate in a panel discussion titled “SleepTech: A Gateway to Brain Health.” Kate Willis, Neurovalens’ vice president of commercialization, will discuss how sleep technologies like Modius Sleep can enhance sleep and cognitive health. Attendees can also visit the NSF booth to learn more about the device and its applications.
Key Takeaways:
- Participation at CES 2025: Neurovalens will take part in an NSF-led panel to discuss the role of sleep technology in improving brain health.
- Focus on Modius Sleep: The FDA-cleared device for chronic insomnia will be showcased as an example of innovative sleep health solutions.
- Hands-On Experience: CES attendees can explore Modius Sleep at the NSF booth, gaining insights into its benefits for sleep health.
As a recipient of the 2024 SleepTech Award in the Sleep Disorders and Conditions category for its Modius Sleep product, Neurovalens has been invited to join NSF at CES 2025 in Las Vegas this January to discuss the future of sleep technology and its role in enhancing brain health.
Modius Sleep is a noninvasive, US Food and Drug Administration-cleared medical device that treats chronic insomnia.
The CES 2025 stage will feature Kate Willis, Neurovalens’ vice president of commercialization, as a panelist. NSF, as part of its role in the AARP AgeTech Collaborative, will lead a panel discussion on the AARP stage and has invited Willis to participate as a co-panelist.
The panel, titled “SleepTech: A Gateway to Brain Health” will be held on Tuesday, Jan 7, from 1 pm to 1:30 pm. The session, also featuring John Lopos, NSF CEO, and Joseph Dzierzewski, NSF senior vice president of research and scientific affairs, will explore the connection between sleep and cognitive wellness, highlighting the role of technologies like Modius Sleep in improving overall brain health.
“We are honored to join the National Sleep Foundation at CES 2025 and humbled to be recognized with the prestigious SleepTech Award. This acknowledgment reinforces our commitment to advancing sleep health through groundbreaking technology. Modius Sleep is not just improving lives—it’s helping reshape the future of sleep and brain health,” says Jason McKeown, CEO of Neurovalens, in a release.
Lopos adds in a release, “NSF is excited to host Neurovalens during our panel at CES 2025 and more broadly feature them among our other SleepTech Award winners and SleepTech Network members. Neurovalens reflects the promise SleepTech has to improve the public’s sleep and health.”
CES attendees can visit Neurovalens at the NSF booth (Booth 53607 in the Venetian) to experience the device firsthand and learn more about how it improves sleep health.
Photo caption: Modius Sleep
File photo/Neurovalens
